Standardized Infant NeuroDevelopmental Assessment (SINDA) has been developed as a screening instrument for infants aged 6 weeks to 12 months corrected age, to assist early detection of infants at high risk of neurodevelopmental disorders. It is the first developmental instrument to allow a comprehensive (360-degree approach) including “all” dimensions of development. It has three scales: a neurological (28 items), developmental (15 items per month of age; total 113 items) and socio-emotional scale (6 items). It can be used quickly in virtually any environment and requires only simple equipment, so excellent when financial and time considerations are important.
Foreword |
|
vii | |
Preface |
|
ix | |
Videos |
|
xi | |
|
|
1 | (4) |
|
2 Early Detection of Infants at High Risk of Neurodevelopmental Disorders |
|
|
5 | (8) |
|
3 Design, Psychometric Properties, and implementation of SINDA |
|
|
13 | (12) |
|
|
25 | (38) |
|
5 The Developmental Scale |
|
|
63 | (98) |
|
6 The Socio-Emotional Scale |
|
|
161 | (6) |
|
7 Significance of SINDA Findings |
|
|
167 | (8) |
References |
|
175 | (4) |
Index |
|
179 | |
Mijna Hadders-Algra, Professor of Developmental Neurology, University Medical Center Groningen Beatrix Children's Hospital, Institute of Developmental Neurology, the Netherlands.
Uta Tacke, Child Neurologist, University Children's Hospital (UKBB), Neuropaediatrics, Haemato-Oncology, Basel, Switzerland.
Joachim Pietz, Paediatrician, specialized in Child Neurology, Palliative Medicine, Center for Child and Adolescent Medicine, Medical Faculty, University of Heidelberg, Heidelberg, Germany.
Heike Philippi, Child Neurologist; Chair of the Centre for Child Neurology (Sozialpädiatrisches Zentrum) Frankfurt Mitte, Frankfurt am Main, and Associate Professor Goethe University Frankfurt am Main, Germany.